DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.54M | -35.10M | -32.77M | -31.93M | -29.58M |
| Total Depreciation and Amortization | 52.00K | 43.00K | 43.00K | 43.00K | 35.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.37M | 3.01M | 2.99M | 2.30M | 1.73M |
| Change in Net Operating Assets | 2.60M | 1.05M | 675.00K | 1.85M | 2.16M |
| Cash from Operations | -31.51M | -31.00M | -29.06M | -27.73M | -25.65M |
| Capital Expenditure | -33.00K | -36.00K | -40.00K | -41.00K | -34.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.61M | -10.89M | -2.15M | -4.94M | 15.23M |
| Cash from Investing | -11.64M | -10.93M | -2.19M | -4.98M | 15.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.00K | -10.00K | -10.00K | -11.00K | -11.00K |
| Issuance of Common Stock | 44.58M | 44.61M | 44.29M | 32.37M | 506.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00K | -400.00K | -400.00K | -456.00K | -- |
| Cash from Financing | 44.17M | 44.20M | 43.88M | 31.91M | 495.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.02M | 2.28M | 12.62M | -808.00K | -9.96M |